US-based contract research organisation (CRO) WIL Research Laboratories and WIL Research Holding Company, which took over the CRO in a management buyout in September 2004, have acquired MidWest BioResearch, a US provider of drug disposition and toxicology services, for an undisclosed sum.

According to WIL, Midwest BioResearch’s expertise in immuno-analytical and bioassay techniques and small molecule bioanalysis, as well as genetic toxicology, complements the WIL Research offerings, which include expertise in chronic, neuro-, inhalation and intravenous toxicology, developmental and reproductive toxicology, safety pharmacology, bioanalytical chemistry and metabolism.

The two companies will integrate their service offerings “through scientific collaboration, sharing of best practices and marketing to provide a seamless bridge between these two highly regarded scientific organisations”, WIL added.

To ensure continuity of management, quality science and service, Dr Michael Schlosser, president and founder of Midwest BioResearch, will continue to head up the company’s existing 16,000sq ft facility in Skokie, Illinois, reporting to Dr Christopher Chengelis, vice president and chief scientific officer of WIL Research.

“Midwest BioResearch rounds out our service offerings, particularly in the areas of genetic toxicity and biotech and clinical support capabilities,” Dr Chengelis commented. “We also benefit from a world-class staff with significant pharmaceutical and biotechnology industry experience and the addition of a programme services consulting group.”

Founded in 1976, WIL is located on a 78-acre campus in Ashland, Ohio with a “growing base” of more than 700 employees. “Among its many scientific services, WIL Research is considered by most experts in the industry to be the worldwide leader in developmental and reproductive toxicology”, WIL noted.

The company was acquired by WIL Research Holding Company as the platform organisation for a global safety assessment and product development scientific outsourcing service group. With the addition of Midwest BioResearch, WIL Research Holding Company now comprises five companies with some 1,100 dedicated scientific, technical and support personnel in the US, Europe and Japan.